CIK 0000939767 · Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043257395
- Phone
- 6508377000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-18 | WYSZOMIERSKI JACK L Director | Option exercise 10b5-1 | +20,634 | $19.77 | $408K | 379,516 |
| 2026-02-18 | WYSZOMIERSKI JACK L Director | Sale 10b5-1 | −99,574 | $44.01 | $4.4M | 279,942 |
| 2026-02-18 | WYSZOMIERSKI JACK L Director | Option exercise · Option (right to buy) 10b5-1 | −20,634 | 0 | ||
| 2026-02-18 | Smith Julie Director | Option exercise | +44,087 | $19.39 | $855K | 64,677 |
| 2026-02-18 | Smith Julie Director | Sale | −44,087 | $44.50 | $2.0M | 20,590 |
| 2026-02-18 | Smith Julie Director | Option exercise | +20,030 | $21.69 | $434K | 40,620 |
| 2026-02-18 | Smith Julie Director | Sale | −20,030 | $44.30 | $887K | 20,590 |
| 2026-02-18 | Smith Julie Director | Option exercise · Option (right to buy) | −44,087 | 0 | ||
| 2026-02-18 | Smith Julie Director | Option exercise · Option (right to buy) | −20,030 | 0 | ||
| 2026-02-18 | MORRISSEY MICHAEL President and CEO | Gift | −125,094 | 1,454,115 | ||
| 2026-02-18 | MORRISSEY MICHAEL President and CEO | Gift | +125,094 | 2,090,234 | ||
| 2026-02-18 | Hefti Brenda SVP and General Counsel | Sale 10b5-1 | −18,669 | $44.01 | $822K | 96,512 |
| 2026-02-17 | Smith Julie Director | Option exercise | +42,422 | $18.19 | $772K | 63,012 |
| 2026-02-17 | Smith Julie Director | Sale | −42,422 | $43.33 | $1.8M | 20,590 |
| 2026-02-17 | Smith Julie Director | Option exercise · Option (right to buy) | −42,422 | 0 | ||
| 2026-02-17 | Senner Christopher J. EVP and CFO | Sale | −30,617 | $43.67 | $1.3M | 976,092 |
| 2026-02-17 | Haley Patrick J. EVP, Commercial | Sale | −3,036 | $43.84 | $133K | 446,686 |
| 2026-02-17 | Haley Patrick J. EVP, Commercial | Sale | −64,778 | $43.50 | $2.8M | 381,908 |
| 2026-02-17 | MORRISSEY MICHAEL President and CEO | Gift | −250,736 | 1,579,209 | ||
| 2026-02-17 | MORRISSEY MICHAEL President and CEO | Gift | +250,736 | 1,965,140 |
Page 3 of 10 · 192 trades